Discovery of a New Inhibitor for PFKFB2 Kinase Activity Through Mechanistic Studies

Applications | 2025 | Agilent TechnologiesInstrumentation
LC/MS/MS, LC/MS, LC/TOF, LC/HRMS
Industries
Metabolomics
Manufacturer
Agilent Technologies
Downloadable PDF for viewing
 

Similar PDF

Extracellular Flux Analysis and 13C Stable-Isotope Tracing Reveals Metabolic Changes in LPS-Stimulated Macrophages
Illuminating the Cellular and Molecular Response to Drug Treatment by Combining Bioenergetic Measurements with LC/MS Omics
Maximizing Efficiency and Performance of Seahorse XF Assays with the Bravo Automated Liquid Handling Platform
Illuminating the Cellular and Molecular Response to Drug Treatment by Combining Bioenergetic Measurements with Untargeted Metabolomics